ALLOPURINOL

ALLOPURINOL was reported 157738 times

ALLOPURINOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 311 0.8036
1 SLEEP DISORDER THERAPY 128 0.6465
2 ANALGESIC THERAPY 145 0.4517
3 DRUG THERAPY 139 0.4100
4 MULTIPLE DRUG THERAPY 126 0.1671
5 TUMOUR FLARE 114 0.1669
6 PRODUCT MONITORING ERROR 226 0.1564
7 HYPERPARATHYROIDISM SECONDARY 359 0.1431
8 HYPERPHOSPHATAEMIA 305 0.1417
9 GOUTY ARTHRITIS 112 0.1404
10 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 140 0.1318
11 NEPHROGENIC ANAEMIA 605 0.1305
12 GOUT 2286 0.1273
13 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3027 0.1175
14 BLOOD URIC ACID INCREASED 679 0.1175
15 HYPERURICAEMIA 471 0.1145
16 BLOOD PHOSPHORUS INCREASED 302 0.1105
17 TUMOUR LYSIS SYNDROME 868 0.0986
18 REBOUND ACID HYPERSECRETION 261 0.0862
19 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 280 0.0862
20 BRONCHIAL SECRETION RETENTION 105 0.0824
21 AORTIC VALVE STENOSIS 147 0.0824
22 PULMONARY FUNCTION TEST ABNORMAL 125 0.0802
23 SYSTEMIC INFECTION 131 0.0790
24 TOXIC EPIDERMAL NECROLYSIS 1187 0.0781
25 CARDIOACTIVE DRUG LEVEL INCREASED 99 0.0753
26 DERMATITIS EXFOLIATIVE GENERALISED 236 0.0678
27 END STAGE RENAL DISEASE 1161 0.0636
28 BENIGN PROSTATIC HYPERPLASIA 325 0.0629
29 CYTOKINE RELEASE SYNDROME 1165 0.0580
30 AORTIC STENOSIS 202 0.0579
31 CHRONIC LYMPHOCYTIC LEUKAEMIA 274 0.0577
32 DIASTOLIC DYSFUNCTION 178 0.0576
33 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 290 0.0572
34 IRON DEFICIENCY 254 0.0564
35 NEUTROPENIC SEPSIS 402 0.0562
36 SPLENOMEGALY 617 0.0526
37 ANAEMIA MACROCYTIC 112 0.0524
38 HYPERKALAEMIA 1839 0.0524
39 DERMATITIS EXFOLIATIVE 254 0.0507
40 STEVENS-JOHNSON SYNDROME 1119 0.0503
41 MYELOFIBROSIS 152 0.0502
42 RENAL FAILURE CHRONIC 385 0.0500
43 PLEURITIC PAIN 137 0.0496
44 FEBRILE NEUTROPENIA 3281 0.0494
45 TOXIC SKIN ERUPTION 480 0.0476
46 HYPOPHOSPHATAEMIA 342 0.0462
47 EOSINOPHILIA 808 0.0461
48 CARDIAC FAILURE CHRONIC 192 0.0450
49 CHRONIC KIDNEY DISEASE 3417 0.0449
50 ACUTE KIDNEY INJURY 6871 0.0449
51 ESCHERICHIA SEPSIS 130 0.0448
52 LUNG CONSOLIDATION 125 0.0446
53 BLOOD UREA INCREASED 748 0.0446
54 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 393 0.0444
55 RENAL FAILURE ACUTE 1883 0.0443
56 CHEST X-RAY ABNORMAL 133 0.0433
57 TACHYARRHYTHMIA 108 0.0432
58 RALES 250 0.0430
59 RASH MORBILLIFORM 117 0.0422
60 ORTHOPNOEA 134 0.0420
61 APPENDICITIS 389 0.0416
62 ESCHERICHIA BACTERAEMIA 97 0.0412
63 VENTRICULAR FIBRILLATION 455 0.0409
64 PURPURA 358 0.0404
65 AZOTAEMIA 161 0.0403
66 DUODENITIS 123 0.0401
67 RASH MACULO-PAPULAR 889 0.0399
68 BRAIN NATRIURETIC PEPTIDE INCREASED 120 0.0389
69 ATRIAL FLUTTER 308 0.0386
70 ISCHAEMIC CARDIOMYOPATHY 118 0.0384
71 HAEMORRHAGIC ANAEMIA 168 0.0382
72 MELAENA 839 0.0381
73 EXERCISE TOLERANCE DECREASED 219 0.0380
74 CARDIOGENIC SHOCK 545 0.0379
75 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1071 0.0378
76 LUNG OPACITY 99 0.0375
77 STAPHYLOCOCCAL SEPSIS 184 0.0372
78 APLASIA PURE RED CELL 127 0.0369
79 BLOOD LACTATE DEHYDROGENASE INCREASED 583 0.0368
80 RENAL FAILURE 4780 0.0360
81 BLOOD POTASSIUM INCREASED 583 0.0359
82 TROPONIN INCREASED 271 0.0356
83 MULTIPLE MYELOMA 165 0.0354
84 TUBULOINTERSTITIAL NEPHRITIS 658 0.0351
85 BLOOD CREATINE INCREASED 155 0.0350
86 BLOOD CREATININE INCREASED 2284 0.0349
87 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 142 0.0347
88 MIXED LIVER INJURY 103 0.0342
89 RED CELL DISTRIBUTION WIDTH INCREASED 142 0.0341
90 STAPHYLOCOCCAL BACTERAEMIA 148 0.0340
91 CREPITATIONS 101 0.0339
92 HYPERVOLAEMIA 167 0.0338
93 PNEUMONIA FUNGAL 133 0.0337
94 APLASTIC ANAEMIA 175 0.0335
95 ATRIOVENTRICULAR BLOCK FIRST DEGREE 145 0.0334
96 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 127 0.0332
97 ACUTE MYELOID LEUKAEMIA 516 0.0331
98 GASTRITIS EROSIVE 154 0.0330
99 DIVERTICULUM INTESTINAL 144 0.0329
100 CLOSTRIDIUM DIFFICILE COLITIS 349 0.0329
101 FIBRIN D DIMER INCREASED 116 0.0326
102 GLOMERULAR FILTRATION RATE DECREASED 399 0.0324
103 ENTEROCOCCAL INFECTION 156 0.0323
104 SQUAMOUS CELL CARCINOMA OF SKIN 194 0.0321
105 ELECTROLYTE IMBALANCE 373 0.0321
106 BREATH SOUNDS ABNORMAL 157 0.0318
107 MITRAL VALVE INCOMPETENCE 360 0.0318
108 INTERNATIONAL NORMALISED RATIO INCREASED 906 0.0317
109 HOSPICE CARE 313 0.0317
110 PANCYTOPENIA 1771 0.0317
111 HYPOVOLAEMIC SHOCK 149 0.0311
112 ECCHYMOSIS 213 0.0310
113 OBSTRUCTION 124 0.0310
114 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 241 0.0310
115 CYTOMEGALOVIRUS VIRAEMIA 138 0.0310
116 HYPONATRAEMIA 1736 0.0308
117 TRICUSPID VALVE INCOMPETENCE 244 0.0307
118 MYASTHENIA GRAVIS 248 0.0307
119 CUTANEOUS VASCULITIS 112 0.0307
120 CUSHINGOID 98 0.0305
121 SERUM FERRITIN INCREASED 161 0.0305
122 PROTHROMBIN TIME PROLONGED 182 0.0304
123 HYPOVOLAEMIA 178 0.0304
124 HYPERLIPIDAEMIA 363 0.0303
125 UROSEPSIS 280 0.0303
126 CARDIAC FAILURE ACUTE 202 0.0303
127 RENAL IMPAIRMENT 2546 0.0303
128 TRANSFUSION 316 0.0301
129 RENAL FUNCTION TEST ABNORMAL 140 0.0301
130 AORTIC VALVE INCOMPETENCE 127 0.0298
131 CARDIOMEGALY 367 0.0298
132 PROSTATOMEGALY 117 0.0297
133 ATELECTASIS 287 0.0297
134 HAEMATOMA 769 0.0297
135 RIGHT VENTRICULAR FAILURE 208 0.0297
136 LUNG INFILTRATION 262 0.0296
137 HYPERCALCAEMIA 364 0.0294
138 RENAL CYST 234 0.0294
139 BLOOD COUNT ABNORMAL 444 0.0293
140 ANURIA 252 0.0293
141 HAEMORRHAGIC DIATHESIS 104 0.0292
142 ATRIAL FIBRILLATION 2815 0.0289
143 ANAEMIA 5511 0.0289
144 UPPER GASTROINTESTINAL HAEMORRHAGE 486 0.0289
145 ASCITES 849 0.0289
146 LEFT VENTRICULAR HYPERTROPHY 123 0.0287
147 HAEMODIALYSIS 241 0.0287
148 HYPERBILIRUBINAEMIA 295 0.0285
149 HYPOMAGNESAEMIA 396 0.0284
150 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 168 0.0283
151 BRONCHIECTASIS 191 0.0283
152 CONGESTIVE CARDIOMYOPATHY 118 0.0283
153 ERYTHEMA MULTIFORME 264 0.0283
154 HAEMATOCRIT DECREASED 559 0.0282
155 PEMPHIGOID 212 0.0281
156 BACTERIAL INFECTION 524 0.0281
157 NEPHROPATHY 262 0.0280
158 CORONARY ARTERY STENOSIS 141 0.0280
159 SEPSIS 3124 0.0280
160 HAEMOGLOBIN DECREASED 2870 0.0279
161 IRON DEFICIENCY ANAEMIA 258 0.0279
162 CARDIAC FAILURE 2241 0.0279
163 ORTHOSTATIC HYPOTENSION 485 0.0278
164 FULL BLOOD COUNT ABNORMAL 293 0.0277
165 BUNDLE BRANCH BLOCK LEFT 117 0.0276
166 METABOLIC ACIDOSIS 881 0.0275
167 THROMBOCYTOPENIA 3078 0.0275
168 ESCHERICHIA URINARY TRACT INFECTION 116 0.0273
169 DYSPNOEA EXERTIONAL 1026 0.0272
170 BUNDLE BRANCH BLOCK RIGHT 125 0.0272
171 PLEURAL EFFUSION 1655 0.0272
172 COVID-19 PNEUMONIA 320 0.0271
173 BLOOD CALCIUM INCREASED 237 0.0270
174 ERYSIPELAS 135 0.0268
175 ACUTE PULMONARY OEDEMA 150 0.0267
176 SUBDURAL HAEMATOMA 382 0.0267
177 INTERNATIONAL NORMALISED RATIO DECREASED 108 0.0266
178 SHOCK HAEMORRHAGIC 217 0.0266
179 HAEMATURIA 902 0.0263
180 HYPOKALAEMIA 1208 0.0261
181 PETECHIAE 273 0.0261
182 SEPTIC SHOCK 1136 0.0261
183 RENAL TUBULAR NECROSIS 254 0.0259
184 GENERAL PHYSICAL HEALTH DETERIORATION 2993 0.0258
185 LEUKOCYTOSIS 467 0.0258
186 LEFT VENTRICULAR DYSFUNCTION 172 0.0257
187 RED BLOOD CELL COUNT DECREASED 732 0.0256
188 ACUTE RESPIRATORY FAILURE 492 0.0255
189 ELECTROCARDIOGRAM ABNORMAL 200 0.0255
190 PLATELET COUNT DECREASED 2695 0.0253
191 HYPOCALCAEMIA 478 0.0252
192 CREATININE RENAL CLEARANCE DECREASED 101 0.0252
193 RENAL INJURY 742 0.0250
194 LACTIC ACIDOSIS 808 0.0249
195 VENTRICULAR TACHYCARDIA 411 0.0249
196 LOWER GASTROINTESTINAL HAEMORRHAGE 184 0.0249
197 HYPERNATRAEMIA 124 0.0249
198 DIALYSIS 353 0.0249
199 BLOOD MAGNESIUM DECREASED 214 0.0248
200 C-REACTIVE PROTEIN INCREASED 901 0.0247
201 WHITE BLOOD CELL COUNT INCREASED 948 0.0247
202 BRADYCARDIA 1309 0.0247
203 BACTERAEMIA 291 0.0245
204 OEDEMA PERIPHERAL 2986 0.0245
205 CHRONIC MYELOID LEUKAEMIA 113 0.0245
206 WHITE BLOOD CELL COUNT ABNORMAL 156 0.0244
207 PULMONARY HYPERTENSION 508 0.0244
208 KLEBSIELLA INFECTION 123 0.0243
209 RHABDOMYOLYSIS 1012 0.0242
210 HAEMORRHOIDAL HAEMORRHAGE 118 0.0241
211 HYDRONEPHROSIS 179 0.0239
212 HYPOGAMMAGLOBULINAEMIA 157 0.0239
213 HAEMOGLOBIN INCREASED 109 0.0239
214 HAEMOGLOBIN ABNORMAL 153 0.0238
215 HYPOXIA 834 0.0237
216 GASTROINTESTINAL HAEMORRHAGE 1973 0.0236
217 CYTOPENIA 289 0.0236
218 BLOOD PRESSURE INADEQUATELY CONTROLLED 142 0.0236
219 MULTI-ORGAN FAILURE 408 0.0236
220 INCREASED TENDENCY TO BRUISE 217 0.0236
221 FLUID OVERLOAD 343 0.0235
222 URINE OUTPUT DECREASED 206 0.0235
223 OBSTRUCTIVE AIRWAYS DISORDER 259 0.0233
224 DIVERTICULUM 165 0.0232
225 INGUINAL HERNIA 141 0.0232
226 INTERVERTEBRAL DISC DEGENERATION 214 0.0231
227 FEBRILE BONE MARROW APLASIA 98 0.0230
228 SKIN ULCER 592 0.0229
229 FULL BLOOD COUNT DECREASED 458 0.0227
230 OLIGURIA 141 0.0227
231 CHOLESTASIS 436 0.0227
232 DERMATITIS BULLOUS 164 0.0226
233 SLEEP APNOEA SYNDROME 430 0.0225
234 PLATELET COUNT ABNORMAL 136 0.0225
235 CORONARY ARTERY DISEASE 679 0.0224
236 AGRANULOCYTOSIS 416 0.0224
237 HYPOALBUMINAEMIA 174 0.0224
238 DRUG ERUPTION 396 0.0223
239 LIPASE INCREASED 171 0.0223
240 HEPATITIS ACUTE 145 0.0223
241 BONE MARROW FAILURE 453 0.0223
242 EJECTION FRACTION DECREASED 346 0.0222
243 SQUAMOUS CELL CARCINOMA 209 0.0222
244 BLOOD ALKALINE PHOSPHATASE INCREASED 551 0.0222
245 FLUID INTAKE REDUCED 111 0.0222
246 FACE OEDEMA 374 0.0222
247 ATRIOVENTRICULAR BLOCK COMPLETE 148 0.0221
248 GAMMA-GLUTAMYLTRANSFERASE INCREASED 490 0.0221
249 DIABETES MELLITUS INADEQUATE CONTROL 391 0.0221
250 HEPATITIS CHOLESTATIC 133 0.0221
251 MYOCARDIAL ISCHAEMIA 250 0.0219
252 PLATELET COUNT INCREASED 286 0.0219
253 CARDIAC FAILURE CONGESTIVE 1760 0.0219
254 MYOPATHY 188 0.0217
255 HAEMOPTYSIS 607 0.0217
256 DRUG INTERACTION 3450 0.0217
257 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 163 0.0217
258 HYPOTENSION 4357 0.0217
259 EPISTAXIS 1620 0.0216
260 ARTERIOSCLEROSIS CORONARY ARTERY 143 0.0216
261 PERICARDIAL EFFUSION 499 0.0216
262 VENTRICULAR EXTRASYSTOLES 224 0.0215
263 ACUTE CORONARY SYNDROME 178 0.0215
264 GASTRIC ULCER HAEMORRHAGE 119 0.0215
265 ESCHERICHIA INFECTION 176 0.0214
266 ACIDOSIS 163 0.0213
267 JOINT EFFUSION 147 0.0213
268 DIFFUSE LARGE B-CELL LYMPHOMA 164 0.0213
269 ODYNOPHAGIA 127 0.0213
270 MUCOSAL INFLAMMATION 556 0.0212
271 ENDOCARDITIS 108 0.0210
272 PRODUCT PRESCRIBING ERROR 501 0.0210
273 MYELODYSPLASTIC SYNDROME 304 0.0210
274 PULMONARY OEDEMA 939 0.0209
275 LOCALISED OEDEMA 97 0.0209
276 DEHYDRATION 2762 0.0207
277 BLOOD BILIRUBIN INCREASED 559 0.0207
278 CELLULITIS 1041 0.0206
279 HYPOGLYCAEMIA 997 0.0205
280 ABNORMAL LOSS OF WEIGHT 140 0.0205
281 PSEUDOMONAS INFECTION 176 0.0205
282 ACUTE MYOCARDIAL INFARCTION 600 0.0203
283 DUODENAL ULCER 143 0.0202
284 NOCTURIA 246 0.0202
285 DIABETIC NEUROPATHY 100 0.0202
286 LEUKOPENIA 1005 0.0201
287 SINUS BRADYCARDIA 194 0.0200
288 BLOOD ALBUMIN DECREASED 159 0.0200
289 HEPATOCELLULAR INJURY 284 0.0200
290 DISSEMINATED INTRAVASCULAR COAGULATION 282 0.0200
291 LYMPHOPENIA 283 0.0200
292 HYPERTRANSAMINASAEMIA 139 0.0200
293 PULMONARY HAEMORRHAGE 156 0.0199
294 ULCER 317 0.0199
295 MOUTH HAEMORRHAGE 145 0.0198
296 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 203 0.0198
297 RESPIRATORY FAILURE 1441 0.0197
298 HAEMOLYTIC ANAEMIA 177 0.0197
299 COAGULOPATHY 326 0.0195
300 BLOOD CALCIUM DECREASED 220 0.0195
301 BLOOD LACTIC ACID INCREASED 103 0.0195
302 FLANK PAIN 183 0.0195
303 ASPARTATE AMINOTRANSFERASE INCREASED 1036 0.0195
304 DYSLIPIDAEMIA 99 0.0195
305 BLOOD SODIUM DECREASED 367 0.0195
306 BLOOD IRON DECREASED 231 0.0194
307 URINARY RETENTION 649 0.0194
308 PULMONARY CONGESTION 256 0.0194
309 ANGINA UNSTABLE 126 0.0194
310 OEDEMA 1051 0.0194
311 RECTAL HAEMORRHAGE 831 0.0193
312 PERIPHERAL SENSORY NEUROPATHY 113 0.0193
313 NEUTROPENIA 2618 0.0192
314 HIATUS HERNIA 249 0.0192
315 BASAL CELL CARCINOMA 300 0.0192
316 GENERALISED OEDEMA 238 0.0192
317 PANCREATITIS ACUTE 431 0.0192
318 INFLAMMATORY MARKER INCREASED 95 0.0191
319 BLOOD TEST ABNORMAL 269 0.0191
320 BRONCHOPULMONARY ASPERGILLOSIS 148 0.0191
321 NEUTROPHIL COUNT DECREASED 777 0.0190
322 SUBARACHNOID HAEMORRHAGE 194 0.0190
323 ALANINE AMINOTRANSFERASE INCREASED 1163 0.0189
324 LYMPHADENOPATHY 670 0.0189
325 SYNCOPE 1882 0.0188
326 PRODUCTIVE COUGH 897 0.0188
327 FLUID RETENTION 953 0.0187
328 ENCEPHALOPATHY 460 0.0187
329 SOPOR 248 0.0187
330 HYPERCHOLESTEROLAEMIA 180 0.0186
331 CHOLECYSTITIS 222 0.0186
332 HEPATOMEGALY 183 0.0186
333 DIVERTICULITIS 516 0.0186
334 CARDIAC MURMUR 161 0.0186
335 ARTERIOSCLEROSIS 175 0.0186
336 RENAL DISORDER 865 0.0185
337 HEPATITIS 475 0.0185
338 POLYNEUROPATHY 221 0.0184
339 CARDIAC PACEMAKER INSERTION 110 0.0184
340 SPUTUM DISCOLOURED 175 0.0184
341 BLOOD PRESSURE DIASTOLIC DECREASED 136 0.0184
342 TRANSAMINASES INCREASED 409 0.0184
343 WHITE BLOOD CELL COUNT DECREASED 1991 0.0183
344 PULMONARY ARTERIAL HYPERTENSION 265 0.0183
345 RASH PUSTULAR 133 0.0182
346 SPINAL OSTEOARTHRITIS 160 0.0182
347 SKIN LACERATION 198 0.0182
348 TACHYPNOEA 246 0.0181
349 PLASMA CELL MYELOMA 705 0.0181
350 RESPIRATORY DISTRESS 498 0.0180
351 SEASONAL ALLERGY 255 0.0180
352 OESOPHAGITIS 196 0.0179
353 ANGINA PECTORIS 514 0.0179
354 HICCUPS 147 0.0179
355 LARGE INTESTINE POLYP 124 0.0179
356 LUNG INFECTION 278 0.0179
357 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 933 0.0179
358 ORAL CANDIDIASIS 235 0.0178
359 BLOOD PRESSURE SYSTOLIC INCREASED 348 0.0178
360 PNEUMONIA 5754 0.0178
361 HEPATIC STEATOSIS 330 0.0177
362 PYREXIA 6125 0.0177
363 ENCEPHALITIS 122 0.0176
364 VASCULITIS 205 0.0176
365 ATRIOVENTRICULAR BLOCK 136 0.0176
366 SUPRAVENTRICULAR TACHYCARDIA 168 0.0175
367 CYTOMEGALOVIRUS INFECTION 291 0.0175
368 ENTERITIS 112 0.0175
369 DERMATITIS ALLERGIC 220 0.0175
370 LIVER FUNCTION TEST ABNORMAL 508 0.0175
371 CARDIOMYOPATHY 258 0.0174
372 BLOOD CREATINE PHOSPHOKINASE INCREASED 501 0.0174
373 CIRCULATORY COLLAPSE 295 0.0173
374 HYPERKERATOSIS 95 0.0172
375 ASPIRATION 188 0.0171
376 HEPATIC FAILURE 517 0.0171
377 CHOLECYSTITIS ACUTE 97 0.0171
378 ACUTE RESPIRATORY DISTRESS SYNDROME 302 0.0171
379 MICTURITION URGENCY 195 0.0171
380 HYPERTHERMIA 130 0.0170
381 CONTUSION 1633 0.0169
382 HAEMATOCHEZIA 936 0.0169
383 CONJUNCTIVITIS 313 0.0169
384 SUDDEN DEATH 178 0.0168
385 PRESYNCOPE 409 0.0168
386 DIZZINESS POSTURAL 163 0.0168
387 HEPATIC CYTOLYSIS 214 0.0168
388 COLITIS ISCHAEMIC 113 0.0167
389 HAEMOLYSIS 129 0.0167
390 LYMPHOCYTE COUNT DECREASED 295 0.0167
391 ILEUS 207 0.0166
392 SINUS TACHYCARDIA 236 0.0166
393 MYOSITIS 149 0.0166
394 SECOND PRIMARY MALIGNANCY 138 0.0166
395 HYPERGLYCAEMIA 604 0.0166
396 NEURALGIA 403 0.0166
397 HYPERTENSIVE CRISIS 184 0.0165
398 STAPHYLOCOCCAL INFECTION 545 0.0165
399 MENTAL STATUS CHANGES 458 0.0165
400 SHOCK 379 0.0165
401 GINGIVAL BLEEDING 225 0.0165
402 HEPATOTOXICITY 364 0.0163
403 CORONARY ARTERY OCCLUSION 224 0.0163
404 DECUBITUS ULCER 133 0.0163
405 PYELONEPHRITIS 141 0.0163
406 HAEMORRHAGIC STROKE 127 0.0162
407 HAEMATEMESIS 412 0.0162
408 LEUKAEMIA 153 0.0162
409 INTERSTITIAL LUNG DISEASE 785 0.0162
410 GASTROENTERITIS 236 0.0162
411 SKIN LESION 443 0.0161
412 CEREBRAL HAEMORRHAGE 577 0.0161
413 PROTEINURIA 306 0.0161
414 DYSURIA 591 0.0160
415 ARRHYTHMIA 757 0.0160
416 AORTIC ANEURYSM 121 0.0159
417 PNEUMONITIS 430 0.0158
418 BLOOD POTASSIUM DECREASED 474 0.0157
419 DELIRIUM 543 0.0156
420 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 268 0.0156
421 FAECES DISCOLOURED 337 0.0155
422 CLOSTRIDIUM DIFFICILE INFECTION 336 0.0154
423 GASTRITIS 405 0.0154
424 POLYURIA 126 0.0154
425 JAUNDICE 414 0.0154
426 PNEUMONIA BACTERIAL 141 0.0153
427 SMALL INTESTINAL OBSTRUCTION 189 0.0153
428 NEPHROTIC SYNDROME 105 0.0153
429 ISCHAEMIC STROKE 273 0.0153
430 GASTRIC ULCER 290 0.0152
431 ASTHENIA 5712 0.0152
432 HEART RATE IRREGULAR 343 0.0152
433 CONFUSIONAL STATE 2452 0.0152
434 CONSTIPATION 3308 0.0152
435 TENDERNESS 158 0.0151
436 PROSTATIC SPECIFIC ANTIGEN INCREASED 208 0.0151
437 HAEMORRHOIDS 293 0.0150
438 TRANSIENT ISCHAEMIC ATTACK 506 0.0150
439 NEPHROPATHY TOXIC 168 0.0150
440 RASH GENERALISED 387 0.0149
441 RIB FRACTURE 307 0.0149
442 DISORIENTATION 591 0.0149
443 EXTRASYSTOLES 104 0.0149
444 BLOOD PRESSURE DECREASED 989 0.0149
445 HYPOPHAGIA 380 0.0148
446 HAEMORRHAGE INTRACRANIAL 222 0.0148
447 ANOREXIA 191 0.0148
448 ANGIOEDEMA 655 0.0148
449 INTERNAL HAEMORRHAGE 169 0.0148
450 LOWER RESPIRATORY TRACT INFECTION 672 0.0148
451 POST PROCEDURAL HAEMORRHAGE 172 0.0148
452 MUSCLE ATROPHY 187 0.0147
453 MYOCLONUS 176 0.0147
454 OBESITY 235 0.0147
455 OXYGEN SATURATION DECREASED 826 0.0147
456 ATAXIA 174 0.0146
457 LIVER FUNCTION TEST INCREASED 313 0.0146
458 RASH PRURITIC 790 0.0146
459 NEUTROPHIL COUNT INCREASED 149 0.0145
460 EOSINOPHIL COUNT INCREASED 121 0.0145
461 BLOOD GLUCOSE FLUCTUATION 159 0.0145
462 BLOOD URINE PRESENT 275 0.0145
463 LYMPHOEDEMA 100 0.0144
464 BODY TEMPERATURE INCREASED 295 0.0144
465 CARDIAC ARREST 1193 0.0144
466 SKIN CANCER 310 0.0144
467 DIABETES MELLITUS 1096 0.0144
468 GASTROOESOPHAGEAL REFLUX DISEASE 1156 0.0143
469 ACUTE HEPATIC FAILURE 196 0.0143
470 ORAL PAIN 320 0.0143
471 PULMONARY FIBROSIS 273 0.0142
472 BLOOD DISORDER 114 0.0142
473 FALL 4725 0.0142
474 DECREASED ACTIVITY 153 0.0142
475 DYSPNOEA 8016 0.0141
476 JOINT INJURY 302 0.0141
477 PERIPHERAL SWELLING 2177 0.0141
478 NEPHROLITHIASIS 648 0.0141
479 PULMONARY MASS 210 0.0141
480 DRUG LEVEL INCREASED 233 0.0141
481 LOCALISED INFECTION 340 0.0140
482 WHEEZING 832 0.0140
483 DISEASE PROGRESSION 1660 0.0140
484 BURSITIS 170 0.0140
485 LARGE INTESTINE PERFORATION 97 0.0140
486 THROMBOSIS 1123 0.0139
487 HAEMODYNAMIC INSTABILITY 106 0.0139
488 URINARY INCONTINENCE 411 0.0139
489 PULMONARY TOXICITY 98 0.0138
490 STOMATITIS 838 0.0138
491 RESPIRATORY TRACT INFECTION 359 0.0138
492 CONTRAINDICATED PRODUCT ADMINISTERED 417 0.0138
493 ELECTROCARDIOGRAM QT PROLONGED 494 0.0137
494 DIARRHOEA 8831 0.0137
495 MALNUTRITION 153 0.0137
496 DRUG-INDUCED LIVER INJURY 428 0.0136
497 HEART RATE DECREASED 479 0.0136
498 PALLOR 370 0.0136
499 HEPATIC FUNCTION ABNORMAL 507 0.0136
500 NEUROTOXICITY 238 0.0136
501 DEVICE RELATED INFECTION 209 0.0136
502 PNEUMOCYSTIS JIROVECII PNEUMONIA 136 0.0135
503 NEUROPATHY PERIPHERAL 1286 0.0135
504 LIVER DISORDER 599 0.0135
505 MUSCULOSKELETAL CHEST PAIN 209 0.0135
506 CONCUSSION 104 0.0134
507 LUNG DISORDER 658 0.0134
508 BLOOD TRIGLYCERIDES INCREASED 237 0.0134
509 PNEUMONIA ASPIRATION 335 0.0134
510 LYMPHOMA 207 0.0134
511 CANDIDA INFECTION 226 0.0134
512 PHARYNGITIS 165 0.0133
513 INTESTINAL PERFORATION 149 0.0133
514 DECREASED APPETITE 3065 0.0132
515 INFUSION SITE PAIN 170 0.0132
516 LACERATION 124 0.0132
517 SPINAL COMPRESSION FRACTURE 109 0.0132
518 URINARY TRACT INFECTION 2232 0.0131
519 HYPERTENSION 2758 0.0130
520 DEMENTIA 361 0.0129
521 SCAB 147 0.0129
522 NIGHT SWEATS 414 0.0128
523 SKIN INFECTION 144 0.0128
524 RASH MACULAR 448 0.0128
525 PULMONARY EMBOLISM 1217 0.0128
526 CHILLS 1500 0.0128
527 COLITIS 485 0.0128
528 RESPIRATORY SYNCYTIAL VIRUS INFECTION 111 0.0127
529 MOUTH ULCERATION 268 0.0127
530 SPINAL PAIN 149 0.0127
531 POLLAKIURIA 530 0.0127
532 INITIAL INSOMNIA 130 0.0127
533 HYPOTHYROIDISM 404 0.0126
534 MUSCULAR WEAKNESS 1434 0.0126
535 EMPHYSEMA 127 0.0126
536 MYOCARDITIS 144 0.0126
537 ABDOMINAL PAIN 2920 0.0125
538 OSTEOMYELITIS 227 0.0125
539 SWOLLEN TONGUE 390 0.0125
540 SKIN HAEMORRHAGE 185 0.0125
541 FUNGAL INFECTION 416 0.0125
542 ABDOMINAL DISTENSION 1300 0.0124
543 TOOTH INFECTION 164 0.0124
544 BODY HEIGHT DECREASED 133 0.0124
545 BRONCHITIS 920 0.0124
546 GASTRIC HAEMORRHAGE 143 0.0124
547 ERECTILE DYSFUNCTION 319 0.0124
548 PARKINSONISM 121 0.0124
549 OSTEOARTHRITIS 526 0.0124
550 OCULAR DISCOMFORT 139 0.0124
551 TASTE DISORDER 251 0.0124
552 SKIN REACTION 174 0.0123
553 HEPATIC ENCEPHALOPATHY 115 0.0123
554 DIARRHOEA HAEMORRHAGIC 115 0.0123
555 DRY MOUTH 998 0.0123
556 ALTERED STATE OF CONSCIOUSNESS 266 0.0123
557 TYPE 2 DIABETES MELLITUS 413 0.0123
558 DEEP VEIN THROMBOSIS 797 0.0123
559 RASH ERYTHEMATOUS 586 0.0122
560 WOUND 342 0.0122
561 TACHYCARDIA 1087 0.0122
562 COUGH 3425 0.0122
563 DEPRESSED LEVEL OF CONSCIOUSNESS 482 0.0122
564 UPPER RESPIRATORY TRACT INFECTION 559 0.0121
565 LETHARGY 695 0.0121
566 ECONOMIC PROBLEM 183 0.0121
567 HEAD INJURY 382 0.0121
568 PANCREATITIS 636 0.0120
569 IMPAIRED HEALING 395 0.0120
570 LABORATORY TEST ABNORMAL 355 0.0120
571 CHOLELITHIASIS 394 0.0120
572 SCIATICA 191 0.0120
573 MOTOR DYSFUNCTION 122 0.0120
574 WOUND INFECTION 131 0.0120
575 MALIGNANT MELANOMA 160 0.0119
576 RHINITIS 96 0.0119
577 DYSARTHRIA 448 0.0119
578 RESPIRATORY RATE INCREASED 105 0.0118
579 HEMIPARESIS 200 0.0118
580 DYSPHONIA 687 0.0117
581 MUSCULOSKELETAL PAIN 615 0.0117
582 BLISTER 658 0.0117
583 EMBOLISM 97 0.0117
584 GROIN PAIN 102 0.0116
585 INFECTION 1677 0.0116
586 TENDON RUPTURE 143 0.0116
587 HALLUCINATION 870 0.0115
588 MEDICATION ERROR 641 0.0115
589 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 110 0.0115
590 WEIGHT DECREASED 3209 0.0115
591 COGNITIVE DISORDER 536 0.0115
592 PAIN IN JAW 324 0.0114
593 BLOOD CHOLESTEROL INCREASED 533 0.0114
594 INFUSION SITE ERYTHEMA 96 0.0114
595 CHROMATURIA 257 0.0114
596 RASH PAPULAR 255 0.0114
597 LIVER INJURY 279 0.0114
598 THIRST 203 0.0114
599 INFUSION RELATED REACTION 753 0.0113
600 FLATULENCE 644 0.0113
601 SWELLING 1057 0.0113
602 CHEST PAIN 2089 0.0113
603 HERNIA 218 0.0113
604 BLOOD PRESSURE ABNORMAL 224 0.0113
605 AGEUSIA 281 0.0113
606 HYPERTHYROIDISM 163 0.0112
607 MIDDLE INSOMNIA 209 0.0112
608 HEPATIC CIRRHOSIS 210 0.0112
609 PERIPHERAL COLDNESS 153 0.0111
610 PULMONARY THROMBOSIS 121 0.0111
611 BODY TEMPERATURE DECREASED 109 0.0111
612 COLON CANCER 165 0.0111
613 BALANCE DISORDER 956 0.0110
614 BLOOD PRESSURE FLUCTUATION 265 0.0110
615 CARDIO-RESPIRATORY ARREST 460 0.0110
616 VITAMIN D DEFICIENCY 107 0.0110
617 CEREBRAL INFARCTION 268 0.0110
618 LIMB INJURY 297 0.0109
619 PNEUMOTHORAX 173 0.0109
620 WEIGHT FLUCTUATION 114 0.0109
621 ABSCESS 173 0.0108
622 CATARACT 645 0.0108
623 ROTATOR CUFF SYNDROME 139 0.0108
624 HERPES ZOSTER 621 0.0108
625 LOSS OF CONSCIOUSNESS 1381 0.0108
626 FATIGUE 8385 0.0108
627 JOINT RANGE OF MOTION DECREASED 144 0.0107
628 PERITONITIS 222 0.0107
629 HYPOTONIA 107 0.0107
630 CYST 132 0.0106
631 MOBILITY DECREASED 763 0.0106
632 SKIN DISCOLOURATION 488 0.0106
633 ARTHRITIS 829 0.0105
634 POOR VENOUS ACCESS 109 0.0105
635 CYSTITIS 334 0.0105
636 TENDONITIS 162 0.0105
637 SWELLING FACE 681 0.0104
638 OSTEOPOROSIS 429 0.0104
639 BACK PAIN 2421 0.0104
640 MYALGIA 1770 0.0104
641 RED BLOOD CELL SEDIMENTATION RATE INCREASED 115 0.0104
642 GLAUCOMA 200 0.0104
643 UNRESPONSIVE TO STIMULI 268 0.0104
644 DIZZINESS 5175 0.0104
645 APHASIA 313 0.0104
646 NODULE 135 0.0103
647 EYE HAEMORRHAGE 138 0.0103
648 LIGAMENT SPRAIN 102 0.0103
649 INFLAMMATION 532 0.0103
650 DRUG INTOLERANCE 995 0.0103
651 PRURITUS GENERALISED 222 0.0103
652 BLOOD PRESSURE INCREASED 1561 0.0102
653 MASS 142 0.0102
654 ANHEDONIA 266 0.0101
655 HYPERSOMNIA 290 0.0101
656 HEPATIC ENZYME INCREASED 686 0.0101
657 PRODUCT ADMINISTRATION ERROR 203 0.0100
658 DERMATITIS 210 0.0100
659 FOLLICULITIS 105 0.0100
660 STATUS EPILEPTICUS 113 0.0100
661 PAIN IN EXTREMITY 2944 0.0100
662 DYSPHAGIA 948 0.0100
663 CARDIAC DISORDER 933 0.0100
664 TOOTH EXTRACTION 124 0.0100
665 RASH 4336 0.0099
666 MUSCLE SPASMS 1821 0.0099
667 BLOOD GLUCOSE ABNORMAL 183 0.0099
668 KIDNEY INFECTION 194 0.0099
669 OSTEOPENIA 150 0.0099
670 JOINT SWELLING 1193 0.0099
671 LIP SWELLING 329 0.0099
672 PRESCRIBED UNDERDOSE 197 0.0099
673 CYANOSIS 155 0.0098
674 SKIN EXFOLIATION 830 0.0098
675 IMMUNODEFICIENCY 146 0.0098
676 VERTIGO 595 0.0098
677 COLD SWEAT 172 0.0097
678 RESPIRATORY DISORDER 291 0.0097
679 DELUSION 151 0.0097
680 VOMITING 4541 0.0096
681 BONE PAIN 565 0.0096
682 CARPAL TUNNEL SYNDROME 135 0.0096
683 RETCHING 205 0.0096
684 CONDITION AGGRAVATED 2915 0.0096
685 SPINAL FRACTURE 192 0.0096
686 HYPOTHERMIA 97 0.0096
687 BACK DISORDER 155 0.0095
688 TOOTH ABSCESS 97 0.0095
689 PHOTOSENSITIVITY REACTION 157 0.0095
690 SOMNOLENCE 1912 0.0095
691 COMA 452 0.0095
692 DYSPEPSIA 933 0.0095
693 HAEMORRHAGE 989 0.0095
694 SINUS DISORDER 187 0.0094
695 BONE DISORDER 172 0.0094
696 SLEEP DISORDER 666 0.0094
697 HALLUCINATION, VISUAL 199 0.0094
698 PRURITUS 3622 0.0094
699 COVID-19 1646 0.0094
700 NAUSEA 7397 0.0093
701 CHEST DISCOMFORT 956 0.0093
702 FLUSHING 942 0.0093
703 DYSSTASIA 270 0.0092
704 GAIT DISTURBANCE 1769 0.0092
705 NEOPLASM 106 0.0092
706 CARDIOVASCULAR DISORDER 234 0.0092
707 NO THERAPEUTIC RESPONSE 112 0.0092
708 TOOTH FRACTURE 101 0.0092
709 EYELID OEDEMA 106 0.0091
710 POST PROCEDURAL COMPLICATION 175 0.0091
711 HIP FRACTURE 293 0.0091
712 FEELING COLD 253 0.0091
713 UPPER LIMB FRACTURE 181 0.0091
714 RENAL PAIN 96 0.0090
715 PHOTOPHOBIA 170 0.0090
716 HYPOACUSIS 389 0.0090
717 DRUG TOXICITY 123 0.0090
718 DEAFNESS 236 0.0090
719 SKIN DISORDER 301 0.0090
720 ECZEMA 472 0.0090
721 ORAL HERPES 176 0.0090
722 POOR QUALITY SLEEP 194 0.0090
723 SARS-COV-2 TEST POSITIVE 119 0.0090
724 ARTHRALGIA 3744 0.0090
725 MUSCULOSKELETAL STIFFNESS 788 0.0090
726 ORAL DISCOMFORT 125 0.0090
727 HOT FLUSH 672 0.0089
728 MUSCLE TWITCHING 205 0.0089
729 MUSCULOSKELETAL DISCOMFORT 153 0.0089
730 INTERVERTEBRAL DISC PROTRUSION 194 0.0089
731 MYOCARDIAL INFARCTION 1547 0.0089
732 VIRAL INFECTION 295 0.0089
733 MUSCLE RIGIDITY 106 0.0089
734 TREMOR 1470 0.0088
735 APHONIA 123 0.0088
736 IMMUNE SYSTEM DISORDER 116 0.0088
737 DENTAL CARIES 97 0.0088
738 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 421 0.0088
739 OROPHARYNGEAL PAIN 810 0.0087
740 THYROID DISORDER 134 0.0087
741 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 202 0.0087
742 ARTHROPATHY 481 0.0086
743 GLYCOSYLATED HAEMOGLOBIN INCREASED 218 0.0086
744 INTESTINAL OBSTRUCTION 324 0.0086
745 DIPLOPIA 223 0.0086
746 ERYTHEMA 1764 0.0086
747 NECK PAIN 478 0.0085
748 TOOTH DISORDER 190 0.0085
749 LOCAL SWELLING 149 0.0085
750 MACULAR DEGENERATION 102 0.0085
751 ABASIA 211 0.0085
752 MALAISE 3741 0.0085
753 CEREBROVASCULAR ACCIDENT 1436 0.0085
754 GASTROENTERITIS VIRAL 153 0.0085
755 NASAL CONGESTION 494 0.0084
756 MALIGNANT NEOPLASM PROGRESSION 860 0.0084
757 FEELING HOT 513 0.0084
758 ERUCTATION 161 0.0083
759 TREATMENT NONCOMPLIANCE 455 0.0083
760 DYSGEUSIA 617 0.0083
761 RESTLESS LEGS SYNDROME 151 0.0083
762 ABDOMINAL DISCOMFORT 1390 0.0083
763 WEIGHT INCREASED 1848 0.0082
764 HYPERHIDROSIS 1056 0.0082
765 BLOOD GLUCOSE INCREASED 1539 0.0082
766 ABDOMINAL PAIN LOWER 206 0.0081
767 SECRETION DISCHARGE 102 0.0081
768 SINUS CONGESTION 110 0.0081
769 DEATH 6985 0.0081
770 HEART RATE INCREASED 802 0.0081
771 SINUSITIS 829 0.0081
772 FEELING JITTERY 154 0.0081
773 DISEASE RECURRENCE 384 0.0081
774 RHINORRHOEA 518 0.0080
775 RESTLESSNESS 293 0.0080
776 PHARYNGEAL OEDEMA 123 0.0080
777 PALPITATIONS 936 0.0080
778 LIMB DISCOMFORT 247 0.0080
779 ABDOMINAL PAIN UPPER 1638 0.0079
780 PARANOIA 137 0.0079
781 NEOPLASM PROGRESSION 276 0.0079
782 ASTHMA 890 0.0079
783 GAIT INABILITY 263 0.0079
784 THERAPY NON-RESPONDER 353 0.0078
785 MOVEMENT DISORDER 252 0.0078
786 OCULAR HYPERAEMIA 371 0.0078
787 PERICARDITIS 131 0.0078
788 HYPOAESTHESIA 1167 0.0078
789 IMPAIRED GASTRIC EMPTYING 106 0.0078
790 OFF LABEL USE 6806 0.0078
791 METASTASES TO BONE 127 0.0077
792 INFLUENZA 862 0.0077
793 PARALYSIS 110 0.0077
794 AMNESIA 499 0.0077
795 EYE PAIN 432 0.0076
796 INTENTIONAL PRODUCT USE ISSUE 668 0.0076
797 JOINT STIFFNESS 199 0.0076
798 DRUG PRESCRIBING ERROR 145 0.0075
799 COORDINATION ABNORMAL 105 0.0075
800 BLINDNESS UNILATERAL 106 0.0075
801 EATING DISORDER 160 0.0075
802 QUALITY OF LIFE DECREASED 100 0.0074
803 METASTASES TO LIVER 131 0.0074
804 FOOT FRACTURE 141 0.0074
805 SENSORY DISTURBANCE 119 0.0074
806 TOOTHACHE 133 0.0073
807 MEMORY IMPAIRMENT 1006 0.0073
808 BLOOD GLUCOSE DECREASED 351 0.0073
809 PRODUCT DOSE OMISSION 477 0.0073
810 SCAR 125 0.0073
811 PARAESTHESIA 1148 0.0073
812 GASTROINTESTINAL DISORDER 652 0.0073
813 CENTRAL NERVOUS SYSTEM LESION 100 0.0073
814 INCREASED APPETITE 139 0.0073
815 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 517 0.0073
816 INSOMNIA 1921 0.0072
817 APATHY 105 0.0072
818 NASOPHARYNGITIS 1324 0.0072
819 LOWER LIMB FRACTURE 138 0.0072
820 SPEECH DISORDER 376 0.0072
821 RESPIRATORY TRACT CONGESTION 114 0.0072
822 SYNOVITIS 129 0.0071
823 OSTEONECROSIS OF JAW 176 0.0071
824 FEEDING DISORDER 144 0.0071
825 KNEE ARTHROPLASTY 149 0.0071
826 THROAT IRRITATION 317 0.0071
827 UNEVALUABLE EVENT 532 0.0070
828 SEDATION 183 0.0070
829 HYPOKINESIA 101 0.0070
830 PAIN 4236 0.0069
831 GALLBLADDER DISORDER 123 0.0069
832 AGITATION 503 0.0068
833 DEPRESSION 1558 0.0068
834 EAR PAIN 133 0.0068
835 DYSKINESIA 278 0.0068
836 ANKLE FRACTURE 105 0.0068
837 HYPERSENSITIVITY 1243 0.0067
838 EYE SWELLING 249 0.0067
839 HOSPITALISATION 1025 0.0067
840 LACRIMATION INCREASED 201 0.0066
841 DEPRESSED MOOD 351 0.0066
842 EYE DISORDER 218 0.0066
843 ANAPHYLACTIC REACTION 365 0.0066
844 TINNITUS 303 0.0066
845 PRESCRIBED OVERDOSE 127 0.0066
846 HEADACHE 4104 0.0065
847 VISUAL ACUITY REDUCED 216 0.0065
848 SKIN FISSURES 127 0.0065
849 EAR INFECTION 172 0.0065
850 FEMUR FRACTURE 200 0.0065
851 INTENTIONAL PRODUCT MISUSE 565 0.0064
852 HIP ARTHROPLASTY 98 0.0064
853 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 108 0.0064
854 FREQUENT BOWEL MOVEMENTS 170 0.0063
855 IMPAIRED WORK ABILITY 134 0.0063
856 PRODUCT USE IN UNAPPROVED INDICATION 1551 0.0063
857 DISTURBANCE IN ATTENTION 337 0.0062
858 SNEEZING 140 0.0062
859 THERAPY INTERRUPTED 445 0.0062
860 ANXIETY 1768 0.0062
861 FEAR 167 0.0062
862 DRY EYE 308 0.0062
863 VISION BLURRED 845 0.0061
864 FRACTURE 116 0.0061
865 TOXICITY TO VARIOUS AGENTS 1022 0.0061
866 VISUAL IMPAIRMENT 751 0.0061
867 PRODUCT DOSE OMISSION IN ERROR 171 0.0060
868 NIGHTMARE 208 0.0060
869 EYE PRURITUS 201 0.0060
870 INJURY 420 0.0060
871 MENTAL IMPAIRMENT 144 0.0059
872 PSYCHOMOTOR HYPERACTIVITY 98 0.0059
873 BLINDNESS 240 0.0059
874 FIBROMYALGIA 143 0.0059
875 NEOPLASM MALIGNANT 392 0.0059
876 THINKING ABNORMAL 109 0.0058
877 DISCOMFORT 355 0.0058
878 FEELING ABNORMAL 1378 0.0057
879 THERAPEUTIC PRODUCT EFFECT DECREASED 257 0.0057
880 ADVERSE DRUG REACTION 515 0.0057
881 ROAD TRAFFIC ACCIDENT 239 0.0057
882 THERAPY CESSATION 292 0.0057
883 ILLNESS 585 0.0057
884 THROAT TIGHTNESS 153 0.0057
885 URTICARIA 942 0.0056
886 BURNING SENSATION 394 0.0056
887 PRODUCT USE ISSUE 1045 0.0056
888 THERAPEUTIC RESPONSE DECREASED 337 0.0056
889 RHEUMATOID ARTHRITIS 631 0.0056
890 RESPIRATORY ARREST 153 0.0055
891 PSORIASIS 723 0.0055
892 MYELOSUPPRESSION 199 0.0055
893 ANAPHYLACTIC SHOCK 142 0.0055
894 ACTIVITIES OF DAILY LIVING IMPAIRED 109 0.0055
895 PAIN OF SKIN 148 0.0055
896 PRODUCT AVAILABILITY ISSUE 125 0.0055
897 GASTRIC DISORDER 188 0.0055
898 DRY SKIN 731 0.0055
899 MUSCULOSKELETAL DISORDER 104 0.0055
900 EPILEPSY 167 0.0055
901 SEIZURE 627 0.0054
902 GLOSSODYNIA 121 0.0054
903 OSTEONECROSIS 177 0.0054
904 CHOKING 105 0.0054
905 HEAD DISCOMFORT 95 0.0054
906 SURGERY 313 0.0053
907 INTENTIONAL DOSE OMISSION 152 0.0053
908 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 288 0.0052
909 PSORIATIC ARTHROPATHY 213 0.0052
910 THERAPEUTIC RESPONSE UNEXPECTED 234 0.0052
911 ABNORMAL BEHAVIOUR 206 0.0052
912 ACCIDENTAL OVERDOSE 190 0.0052
913 PROCEDURAL PAIN 144 0.0052
914 CONVULSION 296 0.0052
915 NERVOUSNESS 267 0.0051
916 DYSTONIA 99 0.0051
917 SEROTONIN SYNDROME 98 0.0051
918 INFLUENZA LIKE ILLNESS 414 0.0050
919 ILL-DEFINED DISORDER 304 0.0050
920 EYE IRRITATION 288 0.0050
921 AGGRESSION 247 0.0049
922 NERVOUS SYSTEM DISORDER 154 0.0049
923 DIABETIC KETOACIDOSIS 118 0.0049
924 PRODUCT DOSE OMISSION ISSUE 1439 0.0049
925 EXTRAPYRAMIDAL DISORDER 121 0.0049
926 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 878 0.0049
927 DRUG DOSE OMISSION 792 0.0048
928 MIGRAINE 436 0.0046
929 LUNG NEOPLASM MALIGNANT 185 0.0045
930 ABNORMAL DREAMS 124 0.0045
931 INCORRECT DOSE ADMINISTERED 1010 0.0044
932 PANCREATIC CARCINOMA 127 0.0044
933 BONE DENSITY DECREASED 137 0.0044
934 PANIC ATTACK 159 0.0044
935 ALOPECIA 850 0.0043
936 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 306 0.0043
937 COLITIS ULCERATIVE 191 0.0043
938 WRONG TECHNIQUE IN DRUG USAGE PROCESS 153 0.0042
939 MENTAL DISORDER 182 0.0042
940 PSYCHOTIC DISORDER 123 0.0042
941 ADVERSE EVENT 378 0.0041
942 PROSTATE CANCER 325 0.0040
943 DRUG ADMINISTRATION ERROR 124 0.0040
944 DRUG INEFFECTIVE 5240 0.0040
945 DRUG RESISTANCE 102 0.0040
946 TREATMENT FAILURE 326 0.0039
947 PREMATURE BABY 116 0.0038
948 IRRITABILITY 229 0.0038
949 MOOD ALTERED 103 0.0038
950 EMOTIONAL DISTRESS 453 0.0037
951 PHARMACEUTICAL PRODUCT COMPLAINT 97 0.0037
952 COMPLETED SUICIDE 308 0.0037
953 DRUG EFFECT INCOMPLETE 134 0.0037
954 UNDERDOSE 258 0.0035
955 SYSTEMIC LUPUS ERYTHEMATOSUS 122 0.0034
956 OVERDOSE 732 0.0034
957 GYNAECOMASTIA 99 0.0032
958 THERAPEUTIC RESPONSE SHORTENED 105 0.0032
959 DRUG EFFECT DECREASED 170 0.0032
960 PRODUCT SUBSTITUTION ISSUE 175 0.0030
961 SUICIDAL IDEATION 273 0.0030
962 EXPIRED PRODUCT ADMINISTERED 98 0.0029
963 SKIN IRRITATION 135 0.0029
964 ANGER 98 0.0029
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 585 0.0029
966 SUICIDE ATTEMPT 175 0.0029
967 PRODUCT QUALITY ISSUE 361 0.0027
968 WITHDRAWAL SYNDROME 105 0.0025
969 DRUG ABUSE 208 0.0025
970 DEVICE MALFUNCTION 174 0.0025
971 EXTRA DOSE ADMINISTERED 99 0.0024
972 INJECTION SITE BRUISING 192 0.0024
973 DEVICE ISSUE 214 0.0024
974 BLADDER CANCER 139 0.0024
975 SKIN BURNING SENSATION 166 0.0023
976 INJECTION SITE PAIN 709 0.0023
977 ACNE 175 0.0023
978 VAGINAL HAEMORRHAGE 99 0.0023
979 RENAL CANCER 105 0.0022
980 INJECTION SITE HAEMORRHAGE 172 0.0022
981 DERMATITIS ATOPIC 109 0.0021
982 INTENTIONAL OVERDOSE 132 0.0021
983 INJECTION SITE ERYTHEMA 250 0.0020
984 INJECTION SITE SWELLING 149 0.0019
985 INJECTION SITE PRURITUS 130 0.0019
986 INJECTION SITE REACTION 115 0.0017
987 NO ADVERSE EVENT 297 0.0016
988 MATERNAL EXPOSURE DURING PREGNANCY 138 0.0015
989 FOETAL EXPOSURE DURING PREGNANCY 123 0.0015
990 MULTIPLE SCLEROSIS RELAPSE 102 0.0015
991 BREAST CANCER 121 0.0013
992 ACCIDENTAL EXPOSURE TO PRODUCT 130 0.0013
993 DRUG WITHDRAWAL SYNDROME 104 0.0012
994 DRUG DEPENDENCE 159 0.0010